Terbinafine: a review of its use in onychomycosis in adults
MJM Darkes, LJ Scott, KL Goa - American journal of clinical dermatology, 2003 - Springer
Terbinafine, an orally and topically active antimycotic agent, inhibits the biosynthesis of the
principal sterol in fungi, ergosterol, at the level of squalene epoxidase. Squalene epoxidase …
principal sterol in fungi, ergosterol, at the level of squalene epoxidase. Squalene epoxidase …
Global perspectives for the management of onychomycosis
Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophyte
molds, and yeasts. This difficult‐to‐treat chronic infection has a tendency to relapse despite …
molds, and yeasts. This difficult‐to‐treat chronic infection has a tendency to relapse despite …
Terbinafine: an update of its use in superficial mycoses
KJ McClellan, LR Wiseman, A Markham - Drugs, 1999 - Springer
Terbinafine is an allylamine antifungal agent which has fungicidal activity against a wide
variety of dermatophytes, moulds and certain dimorphic fungi, and fungistatic activity against …
variety of dermatophytes, moulds and certain dimorphic fungi, and fungistatic activity against …
How often does oral treatment of toenail onychomycosis produce a disease-free nail?: An analysis of published data
E Epstein - Archives of dermatology, 1998 - jamanetwork.com
Objective To analyze studies on oral treatment of toenail onychomycosis so as to aid
clinicians and patients in making informed decisions. Data Sources Studies dealing with …
clinicians and patients in making informed decisions. Data Sources Studies dealing with …
Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality
B Elewski, A Tavakkol - Therapeutics and clinical risk management, 2005 - Taylor & Francis
Clinicians now have five oral antifungal therapeutic agents to choose from when assessing
the risk–benefits associated with a particular treatment for onychomycosis (OM): griseofulvin …
the risk–benefits associated with a particular treatment for onychomycosis (OM): griseofulvin …
A clinical and mycological study of onychomycosis in HIV infection
A Surjushe, R Kamath, C Oberai, D Saple… - Indian Journal of …, 2007 - ijdvl.com
Background: Onychomycosis is one of the early manifestations of HIV infection with a
prevalence of 15-40%. Multiple nail involvement, isolation of both common and rare species …
prevalence of 15-40%. Multiple nail involvement, isolation of both common and rare species …
A practical guide to curing onychomycosis: how to maximize cure at the patient, organism, treatment, and environmental level
AK Gupta, SG Versteeg, NH Shear, V Piguet… - American journal of …, 2019 - Springer
Onychomycosis is a fungal nail infection caused by dermatophytes, non-dermatophyte
molds, and yeasts. Treatment of this infection can be difficult, with relapse likely to occur …
molds, and yeasts. Treatment of this infection can be difficult, with relapse likely to occur …
The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus
GEJ Rodwell, CL Bayles, L Towersey… - International journal of …, 2008 - Wiley Online Library
Background It is not known whether human immunodeficiency virus (HIV) infection is
associated with an increased susceptibility to dermatophytes. Methods In this study, we …
associated with an increased susceptibility to dermatophytes. Methods In this study, we …
Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosis
Introduction Terbinafine has been a cornerstone in dermatophyte infection treatment.
Despite its global efficacy, the emergence of terbinafine resistance raises concerns …
Despite its global efficacy, the emergence of terbinafine resistance raises concerns …
Terbinafine in the treatment of onychomycosis: a review of its efficacy in high‐risk populations and in patients with nondermatophyte infections
BJ Cribier, R Bakshi - British Journal of Dermatology, 2004 - academic.oup.com
Background The prevalence of onychomycosis is higher in certain high‐risk populations,
such as the immunocompromised, diabetics and human immunodeficiency virus (HIV) …
such as the immunocompromised, diabetics and human immunodeficiency virus (HIV) …